Challenges of addiction treatment with opioid agonist drugs from the perspective of stakeholders: A qualitative study

References

• 1.
  Hemmati A, Yaghoobi SF, Hatami H, Shadnoush M, Baniasadi M. Assessing anthropometric indices changes and related factors in patients under methadone maintenance therapy. Koomesh 2018; 20: 447-452. (Persian).
• 2.
  Eskandarieh S, Jafari F, Yazdani S, Hazrati N, Saberi-Zafarghandi MB. Compulsory maintenance treatment program amongst Iranian injection drug users and its side effects. Int J High Risk Behav Addict 2014; 3: e21765.https://doi.org/10.5812/ijhrba.21765PMid:25741482 PMCid:PMC4331656.
• 3.
  Roshanpajouh M, Mirkazemi R, Ehterami M, Narenjiha H, Afzali HM, Sarrami H, et al. The prevalence of drug and stimulant substance abuse among households in Tehran Province, Iran. J Sch Publ Health Instit Publ Health Res 2019; 16. (Persian).
• 4.
  United Nations Office on Drugs and Crime: World Drug Report 2021. https://www.unodc.org/unodc/en/data-and-analysis/wdr2021.html.
• 5.
  Saberi-Zafarghandi MB, Jadidi M, Khalili N. Iran's activities on prevention, treatment and harm reduction of drug abuse. Int J High Risk Behav Addict 2015; 4.https://doi.org/10.5812/ijhrba.22863PMid:26870709 PMCid:PMC4744908##.
• 6.
  Sotodehasl N, Mahigir S, Paknazar F, Mirmohammadkhani M. A comparative study of the attitude of patients participating in narcotics anonymous program and undergoing methadone maintenance therapy towards substance abuse. Koomesh 2020; 22: 550-555. (Persian).https://doi.org/10.29252/koomesh.22.3.550.
• 7.
  Mokri A, Noruzi A. Protocol on management of opioid dependence with methadone. office of prevention and treatment of substance abuse; office of mental, social and addiction Health; Third Edition, Fall 2014. (Persian).
• 8.
  Saberi Zafarghandi M. Some of the challenges of mental health and addiction in Iran. Iran J Psychiatr Clin Psychol 2011; 17: 161-157. (Persian).
• 9.
  Dehkohneh SG, Azadi S, Rasouali-Azad M, Jalilian J, Ghasemineghad A, Vahed N, et al. Oxidative stress, glycemic control, inflammation, and lipid profiles in substance abuse disorders: Current knowledge and future perspectives. Int J Pharmac Res 2020; 12: 1062-1071.
• 10.
  Shanmugam PK. Exploring trends and challenges from mandated treatment to voluntary treatment outcomes in addiction treatment in Malaysia: moving toward a person-centered service provision. J Subst Use 2020; 25: 141-145.https://doi.org/10.1080/14659891.2019.1664669.
• 11.
  Lin C, Wu Z, Rou K, Pang L, Cao X, Shoptaw S, et al. Challenges in providing services in methadone maintenance therapy clinics in China: service providers' perceptions. Int J Drug Policy 2010; 21: 173-178.https://doi.org/10.1016/j.drugpo.2009.09.002PMid:19818591 PMCid:PMC2847064.
• 12.
  Bobrova N, Rughnikov U, Neifeld E, Rhodes T, Alcorn R, Kirichenko S, et al. Challenges in providing drug user treatment services in Russia: providers' views. Subst Use Misuse 2008, 43: 13.https://doi.org/10.1080/10826080802289291PMid:19016164.
• 13.
  Zamani S. Methadone Maintenance Treatment (MMT) for drug-using prisoners in Ghezel Hesar Prison, Karaj, Iran. A qualitative study Kyoto, Japan: UNAIDS/Collaborating Centre on Socio-Epidemiological HIV Research, Kyoto University. 2008. https://www.unodc.org/documents/islamicrepublicofiran/publications/Sub-programme2Documents/17may2015QualitativerepMMTGhezelHesarprison.pdf.
• 14.
  Jeske CP, O'Byrne P. Perceptions and experiences of methadone Maintenance treatment: a qualitative descriptive research study. J Addic Nurs 2019; 30: 24853.https://doi.org/10.1097/JAN.0000000000000307PMid:31800515.
• 15.
  Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 2007; 19: 349-357.https://doi.org/10.1093/intqhc/mzm042PMid:17872937.
• 16.
  Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today 2004; 24: 105-112.https://doi.org/10.1016/j.nedt.2003.10.001PMid:14769454.
• 17.
  Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res 2005; 15: 1277-1288.https://doi.org/10.1177/1049732305276687PMid:16204405.
• 18.
  Andryushchenko V, Kalish N, Kurdil N. The features of the course of combined poisonings with "street" methadone. Emer Med 2018; 136-141.
• 19.
  Reddon H, Ho J, DeBeck K, Milloy M-J, Liu Y, Dong H, et al. Increasing diversion of methadone in Vancouver, Canada, 2005-2015. J Subst Abuse Treat 2018; 85: 10-16.https://doi.org/10.1016/j.jsat.2017.11.010PMid:29291766 PMCid:PMC5753607.
• 20.
  Riahi A, Khanjani N, Ahmadipoor H. Factors related to treatment failure in patients under methadone treatment at drug rehabilitation centers. J Health Base Res 2015; 1: 115-122.
• 21.
  Peyrovi H, Seyedfatemi N, Jalali A. The role of family atmosphere in the relapse behavior of Iranian opiate users: a qualitative study. J Caring Sci 2015; 4: 189.https://doi.org/10.15171/jcs.2015.019PMid:26464835 PMCid:PMC4591608.
• 22.
  Llanes C, lvarez AI, Pastor MT, Garzn M, Gonzlez-Garca N, Montejo L. Sexual dysfunction and quality of life in chronic heroin-dependent individuals on methadone maintenance treatment. J Clin Med 2019; 8: 321.https://doi.org/10.3390/jcm8030321PMid:30866482 PMCid:PMC6463066.
• 23.
  Yee A, Loh HS, Loh HH, Riahi S, Ng CG, bin Sulaiman AH. A comparison of sexual desire in opiate-dependent men receiving methadone and buprenorphine maintenance treatment. Ann Gen Psychiatry 2019; 18: 1-8.https://doi.org/10.1186/s12991-019-0249-zPMid:31649742 PMCid:PMC6805364.
• 24.
  Ezzati E, Jalali A, Hasanpour-Dehkordi A. Exploring the effectiveness of methadone treatment from the perspective of drug users and their families: a qualitative study in Iran. J Soc Work Pract Addict 2020; 20: 230-237. (Persian).https://doi.org/10.1080/1533256X.2020.1793065.